CBAK ENERGY TECHNOLOGY INC (CBAT)

US14986C1027 - Common Stock

1.05  +0.02 (+1.94%)

After market: 1.026 -0.02 (-2.29%)

Fundamental Rating

4

Taking everything into account, CBAT scores 4 out of 10 in our fundamental rating. CBAT was compared to 87 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CBAT have multiple concerns. CBAT has a decent growth rate and is not valued too expensively.



3

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
CBAT had a positive operating cash flow in the past year.
In the past 5 years CBAT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of CBAT (-0.87%) is better than 64.71% of its industry peers.
CBAT has a Return On Equity of -2.17%. This is in the better half of the industry: CBAT outperforms 65.88% of its industry peers.
CBAT's Return On Invested Capital of 1.74% is fine compared to the rest of the industry. CBAT outperforms 61.18% of its industry peers.
Industry RankSector Rank
ROA -0.87%
ROE -2.17%
ROIC 1.74%
ROA(3y)6.23%
ROA(5y)0.39%
ROE(3y)11.99%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of CBAT (1.66%) is comparable to the rest of the industry.
CBAT has a Gross Margin (17.26%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CBAT has grown nicely.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 17.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.6%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CBAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CBAT has more shares outstanding
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
CBAT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
CBAT's Altman-Z score of 0.30 is in line compared to the rest of the industry. CBAT outperforms 48.24% of its industry peers.
CBAT has a debt to FCF ratio of 3.05. This is a good value and a sign of high solvency as CBAT would need 3.05 years to pay back of all of its debts.
CBAT's Debt to FCF ratio of 3.05 is amongst the best of the industry. CBAT outperforms 82.35% of its industry peers.
CBAT has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
CBAT has a Debt to Equity ratio (0.29) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.05
Altman-Z 0.3
ROIC/WACC0.22
WACC7.74%

2.3 Liquidity

A Current Ratio of 0.80 indicates that CBAT may have some problems paying its short term obligations.
The Current ratio of CBAT (0.80) is worse than 92.94% of its industry peers.
A Quick Ratio of 0.59 indicates that CBAT may have some problems paying its short term obligations.
The Quick ratio of CBAT (0.59) is worse than 87.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.59

6

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -20.00% in the last year.
The Revenue for CBAT has decreased by -17.81% in the past year. This is quite bad
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.98% yearly.
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q83.33%
Revenue 1Y (TTM)-17.81%
Revenue growth 3Y75.84%
Revenue growth 5Y52.98%
Revenue growth Q2Q3.16%

3.2 Future

The Earnings Per Share is expected to grow by 100.00% on average over the next years. This is a very strong growth
CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.97% yearly.
EPS Next Y-50%
EPS Next 2Y100%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.51%
Revenue Next 2Y30.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
CBAT is valuated quite expensively with a Price/Forward Earnings ratio of 51.47.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBAT indicates a somewhat cheap valuation: CBAT is cheaper than 67.06% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. CBAT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 51.47

4.2 Price Multiples

94.12% of the companies in the same industry are more expensive than CBAT, based on the Enterprise Value to EBITDA ratio.
97.65% of the companies in the same industry are more expensive than CBAT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.34
EV/EBITDA 6.85

4.3 Compensation for Growth

CBAT's earnings are expected to grow with 100.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (4/26/2024, 7:00:00 PM)

After market: 1.026 -0.02 (-2.29%)

1.05

+0.02 (+1.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap94.42M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.47
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.87%
ROE -2.17%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.66%
PM (TTM) N/A
GM 17.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.8
Quick Ratio 0.59
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-50%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.81%
Revenue growth 3Y75.84%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y